Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants

被引:101
作者
Ninin, E
Milpied, N
Moreau, P
André-Richet, B
Morineau, N
Mahé, B
Vigier, M
Imbert, BM
Morin, O
Harousseau, JL
Richet, H
机构
[1] CHU Nantes, Hop Nantes, Inst Biol, Lab Bacteriol Virol Hyg Hosp, F-44093 Nantes 01, France
[2] CHU Nantes, Parasitol Lab, F-44035 Nantes, France
[3] CHU Nantes, Hematol Serv, F-44035 Nantes 01, France
关键词
D O I
10.1086/320871
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The epidemiology of infections was studied in a retrospective cohort of 446 recipients of bone marrow transplants (BMTs; 92 of which were allogeneic and 354 of which were autologous) during 1993-1996. Infections that were microbiologically documented in 274 recipients included bacteremia, urinary tract infections, cytomegalovirus viremia, fungemia, invasive aspergillosis, and catheter-related infections. During the period of neutropenia, no differences were found between recipients of allogeneic BMTs and recipients of autologous BMTs with regard to the incidence and the nature of infection. After patients underwent engraftment, bacteremia, cytomegalovirus viremia, and invasive aspergillosis were significantly more common in recipients of allogeneic BMTs than in recipients of autologous BMTs. Deaths caused by infection were uncommon and were mainly the result of invasive aspergillosis. Therefore, empirical antimicrobial therapy should be the same for recipients of both allogeneic and autologous BMTs during the period of neutropenia; after engraftment, more attention should be paid to the risk of infection in allogeneic BMT recipients, particularly with regard to detection and prevention of invasive aspergillosis.
引用
收藏
页码:41 / 47
页数:7
相关论文
共 22 条
  • [1] Invasive aspergillosis
    Denning, DW
    [J]. CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) : 781 - 803
  • [2] Early infection in bone marrow transplantation: Quantitative study of clinical factors that affect risk
    Engels, EA
    Ellis, CA
    Supran, SE
    Schmid, CH
    Barza, M
    Schenkein, DP
    Koc, Y
    Miller, KB
    Wong, JB
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 28 (02) : 256 - 266
  • [3] ENRIGHT H, 1993, TRANSPLANTATION, V55, P1339
  • [4] Blood and marrow transplantation activity in Europe 1995
    Gratwohl, A
    Hermans, J
    Baldomero, H
    [J]. BONE MARROW TRANSPLANTATION, 1997, 19 (05) : 407 - 419
  • [5] THE EPIDEMIOLOGY OF PSEUDOMONAS-AERUGINOSA IN ONCOLOGY PATIENTS IN A GENERAL-HOSPITAL
    GRIFFITH, SJ
    NATHAN, C
    SELANDER, RK
    CHAMBERLIN, W
    GORDON, S
    KABINS, S
    WEINSTEIN, RA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1989, 160 (06) : 1030 - 1036
  • [6] RISK-FACTORS FOR FUNGAL INFECTION IN PATIENTS WITH MALIGNANT HEMATOLOGIC DISORDERS - IMPLICATIONS FOR EMPIRICAL THERAPY AND PROPHYLAXIS
    GUIOT, HFL
    FIBBE, WE
    VANTWOUT, JW
    [J]. CLINICAL INFECTIOUS DISEASES, 1994, 18 (04) : 525 - 532
  • [7] IMBERTMARCILLE BM, 1995, BONE MARROW TRANSPL, V15, P611
  • [8] Infections following peripheral blood progenitor cell transplantation for lymphoproliferative malignancies: Etiology and potential risk factors
    Ketterer, N
    Espinouse, D
    Chomarat, M
    Dumontet, C
    Moullet, I
    Rieux, C
    Neidhardt-Berard, EM
    Bouafia, F
    Coiffier, B
    Salles, G
    [J]. AMERICAN JOURNAL OF MEDICINE, 1999, 106 (02) : 191 - 197
  • [9] Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation
    Larocco, MT
    Burgert, SJ
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (02) : 277 - +
  • [10] LJUNGMAN P, 1994, BONE MARROW TRANSPL, V13, P209